Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 72611-716

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 72611-716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almaject, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton (Carton)

Carton (Carton)
This is a pharmaceutical product called Dexrazoxane for Injection. It is a sterile and pyrogen-free substance packaged in a single-dose vial. The vial contains 500 mg of dexrazoxane hydrochloride equivalent to 1050mg dexrazoxane. Upon reconstitution with 50 mL of Sterile Water for Injection, the solution becomes stable for 30 minutes at room temperature. It can be stored in refrigeration up to 3 hours from the time of reconstitution. Prior to administration via IV drip, further dilution with Lactated Ringer's Injection is necessary. The storage temperature is between 20°to 25°C (66° to 77°F). The manufacturer of this product is Gland Pharma Limited in Hyderabad, India, and it is distributed by Almaject Inc. in Morristown, USA.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image
Logo (Logo)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Vial-label (Vial Label)

Vial-label (Vial Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.